Dexcom Q3 revenue $1.344 billion
Dexcom reported 11% year-over-year revenue growth to $1.344 billion, raising fiscal 2026 guidance and authorizing a $1 billion share repurchase program.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed